🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an expanded access program (EAP) designed to allow access to deucri...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT07759141
Treatments Being Tested
This is a Phase 3, multicenter, long-term, open-label study to evaluate the...
Status
Recruiting
Location
Study Site
Start Date
2025-02-01
Trial ID
NCT06679881
Treatments Being Tested
This study evaluates the efficacy of orally administered deucrictibant for ...
Status
Completed
Location
Study site
Start Date
2021-02-03
Trial ID
NCT04618211
Treatments Being Tested
To assess the efficacy of prophylactic treatment with deucrictibant extende...
Status
Recruiting
Location
Institute For Asthma & Allergy
Start Date
2025-03-10
Trial ID
NCT07046806
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlle...
Status
Active Not Recruiting
Location
Study Site
Start Date
2024-12-01
Trial ID
NCT06669754
Treatments Being Tested
This study evaluates the safety and efficacy of PHA-022121 administered ora...
Status
Terminated
Location
Study site
Start Date
2022-04-19
Trial ID
NCT05047185
Treatments Being Tested
This study evaluates the safety and efficacy of long-term on-demand treatme...
Status
Enrolling By Invitation
Location
Study site
Start Date
2022-12-28
Trial ID
NCT05396105
Treatments Being Tested
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlle...
Status
Completed
Location
Study Site
Start Date
2024-02-26
Trial ID
NCT06343779
Treatments Being Tested
This is a Phase 3, multicenter, 3-part study, with 2 randomized, double-bli...
Status
Recruiting
Location
Study Site
Start Date
2025-10-16
Trial ID
NCT07266805
Treatments Being Tested